Will-340B-Pilot-Trigger-a-Financial-Nosedive-for-Covered-Entities

By Gina ShawIf hospital pharmacy leaders have not already modeled worst-case scenarios for the new 340B Rebate Model Pilot Program that launched in January, they’d better get started right away. The pilot fundamentally reverses how covered entities (CEs) receive 340B savings, requiring them to front the full cost of certain drugs, submit detailed claims-level data, and wait for rebates that may or may not arrive on time—or at all.figure img { width:100% !important; } figcaption { pad